SynthesisPloS one2016

Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability.

Emilia Bigaeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.